• Abiraterone Acetate in Prostate Cancer: Precision Inhibition

  2026-05-07

  Explore the unique role of Abiraterone acetate as a potent CYP17 inhibitor in translational prostate cancer research. This article delves into advanced assay optimization, mechanistic depth, and the application of patient-derived 3D models for next-generation insights.

• NAD+ in Metabolic Stress: Rethinking Autophagy for Translati

  2026-05-06

  This article provides mechanistic and strategic guidance for translational researchers by dissecting the evolving role of Nicotinamide Adenine Dinucleotide (NAD+) in metabolic stress responses and autophagy. Drawing upon recent evidence that challenges canonical AMPK-autophagy signaling, we integrate experimental design insights, competitive product positioning, and translational considerations, while referencing both foundational literature and advanced workflow content.

• Lipo3K Transfection Reagent: Precision Tools for Drug Resist

  2026-05-06

  Explore how Lipo3K Transfection Reagent empowers advanced gene expression and RNA interference studies, especially in models of drug-resistant cancer. Dive deep into mechanistic insights and protocol optimization for high-efficiency nucleic acid delivery.

• Erastin (SKU B1524): Practical Solutions for Ferroptosis Ass

  2026-05-05

  This article guides biomedical researchers through real-world challenges in ferroptosis research and oxidative stress assays, illustrating how Erastin (SKU B1524) from APExBIO delivers reliable, reproducible results. Scenario-driven Q&A blocks offer practical workflow insights, rigorous protocol parameters, and transparent vendor selection advice—grounding Erastin’s advantages in evidence and professional lab experience.

• Drosha Regulates Glomerular Capillary Tuft Formation via Gat

  2026-05-05

  This study demonstrates that Drosha in mesangial cells is essential for proper glomerular capillary tuft formation during kidney development, acting through the regulation of ribosomal protein genes and Gata3 translation. The findings reveal a critical mesangial-specific role for Drosha and provide new genetic insight into congenital anomalies of the kidney and urinary tract (CAKUT).

• Ridaforolimus (Deforolimus): Potent mTOR Inhibitor for Cance

  2026-05-04

  Ridaforolimus (Deforolimus, MK-8669) is a nanomolar-potency, selective mTOR inhibitor that robustly suppresses cell proliferation and angiogenesis in diverse cancer models. Its mechanism and utility are well-supported by quantitative evidence. This article details its biological rationale, mechanism, benchmarks, and integration into experimental workflows.

• CB-5083: Optimizing p97 Inhibitor Workflows for Oncology Res

  2026-05-04

  CB-5083, a selective p97 inhibitor from APExBIO, empowers translational researchers to disrupt protein homeostasis and induce apoptosis in cancer models with nanomolar precision. This article delivers actionable workflows, troubleshooting strategies, and insights from recent breakthroughs in ER protein quality control.

• Imipenem: Broad-Spectrum Semisynthetic Thienamycin Antibioti

  2026-05-03

  Imipenem is a semisynthetic thienamycin antibiotic with robust activity against gram-negative and gram-positive bacteria. Its mechanism involves high-affinity inhibition of PBPs, leading to disruption of bacterial cell wall synthesis. Imipenem enhances phagocytosis in vitro and improves survival in sepsis animal models when used under specific conditions.

• HDAC Inhibitors Potentiate Oncolytic HSV in Malignant Mening

  2026-05-02

  Kawamura et al. (2022) demonstrate that histone deacetylase inhibitors, including Panobinostat (LBH589), enhance the efficacy of oncolytic herpes simplex virus (oHSV) therapy in malignant meningioma models. This combinatorial approach increases viral infectivity and tumor cell killing, with transcriptomic evidence for altered mRNA processing, pointing to novel mechanistic synergies and translational potential.

• Deep Learning Reveals Cardiotoxicity in iPSC-CM Drug Screens

  2026-05-01

  Grafton et al. introduce a scalable deep learning platform for cardiotoxicity detection using high-content imaging of human iPSC-derived cardiomyocytes. This study advances early-stage drug safety screening by enabling rapid and phenotype-driven identification of compounds with arrhythmogenic potential.

• EdU Imaging Kits (Cy3): Precision S-Phase Measurement Workfl

  2026-05-01

  EdU Imaging Kits (Cy3) empower researchers to sensitively quantify cell proliferation during the S-phase, outperforming traditional BrdU methods with denaturation-free, click chemistry-based detection. This article unpacks experimental workflows, troubleshooting strategies, and real-world applications—bridging evidence from genotoxicity and cancer microenvironment research.

• Entinostat (MS-275): HDAC1/3 Inhibition from Cancer to Regen

  2026-04-30

  Discover how Entinostat (MS-275) advances cancer research and regenerative biology by targeting HDAC1 and HDAC3. This article uniquely integrates mechanistic insights with translational assay guidance, grounded in recent findings from axolotl limb regeneration.

• Erastin as a Ferroptosis Inducer: Workflows & Troubleshootin

  2026-04-30

  Erastin has become the gold-standard ferroptosis inducer for dissecting iron-dependent cell death, especially in RAS/BRAF mutant cancer cells. This guide distills the latest experimental insights, workflow enhancements, and troubleshooting strategies to accelerate ferroptosis research using Erastin from APExBIO.

• Bradykinin (BA5201): Technical Guidance for Vascular Researc

  2026-04-29

  Bradykinin (SKU BA5201) addresses core experimental needs in endothelium-dependent vasodilator studies, including vascular permeability, smooth muscle contraction, and pain or inflammation signaling. This guide provides precise usage, storage, and troubleshooting parameters to maximize reproducibility. Bradykinin should not be used in diagnostic or clinical workflows, and its limitations in long-term solution stability require special handling.

• XAV-939 (SKU A1877): Reliable Tankyrase Inhibition in Wnt Pa

  2026-04-29

  This evidence-based article presents scenario-driven solutions for researchers using XAV-939 (SKU A1877) in cell viability, proliferation, and differentiation assays. By addressing common laboratory challenges—ranging from mechanistic interpretation to practical protocol optimization—we demonstrate how XAV-939 from APExBIO ensures reproducibility, sensitivity, and enhanced workflow confidence for Wnt/β-catenin pathway investigations.

14843 records 1/990 page Next 12345 下5页 Last page